Roberto Contestabile

Pubblicazioni

Titolo Pubblicato in Anno
Corrigendum to “Pyridoxine-5′-phosphate oxidase (Pnpo) deficiency: Clinical and biochemical alterations associated with the C.347g > A (P.·Arg116gln) mutation” [Mol. Genet. Metab. 122/1–2 (2017) 135–142] MOLECULAR GENETICS AND METABOLISM 2018
Differential inhibitory effect of a pyrazolopyran compound on human serine hydroxymethyltransferase-amino acid complexes ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 2018
The catalytic activity of serine hydroxymethyltransferase is essential for de novo nuclear dTMP synthesis in lung cancer cells THE FEBS JOURNAL 2018
The MocR-like transcription factors: pyridoxal 5'-phosphate-dependent regulators of bacterial metabolism THE FEBS JOURNAL 2018
Human cytosolic and mitochondrial serine hydroxymethyltransferase isoforms in comparison: full kinetic characterization and substrate inhibition properties BIOCHEMISTRY 2018
Study of DNA binding and bending by Bacillus subtilis GabR, a PLP-dependent transcription factor BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS 2017
Salmonella typhimurium PtsJ is a novel MocR-like transcriptional repressor involved in regulating the vitamin B6 salvage pathway THE FEBS JOURNAL 2017
Pyridoxine-5'-phosphate oxidase (pnpo) deficiency. clinical and biochemical alterations associated with the c.347g>a (pp. arg116gln) mutation MOLECULAR GENETICS AND METABOLISM 2017
Biochemical data from the characterization of a new pathogenic mutation of human pyridoxine-5'-phosphate oxidase (PNPO) DATA IN BRIEF 2017
A pyrazolopyran derivative preferentially inhibits the activity of human cytosolic hydroxymethyltransferase and induces cell death in lung cancer cells ONCOTARGET 2016
A bioinformatics analysis reveals a group of MocR bacterial transcriptional regulators linked to a family of genes coding for membrane proteins BIOCHEMISTRY RESEARCH INTERNATIONAL 2016
Structural properties of the linkers connecting the n- and c- terminal domains in the mocr bacterial transcriptional regulators BIOCHIMIE OPEN 2016
Data from computational analysis of the peptide linkers in the mocr bacterial transcriptional regulators DATA IN BRIEF 2016
Differential 3-bromopyruvate inhibition of cytosolic and mitochondrial human serine hydroxymethyltransferase isoforms, key enzymes in cancer metabolic reprogramming BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS 2016
Inhibition of human pyridoxal kinase by 2-acetyl-4-((1R,2S,3R)-1,2,3,4-1 tetrahydroxybutyl)-imidazole (THI) JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 2015
How pyridoxal 5'-phosphate differentially regulates human cytosolic and mitochondrial serine hydroxymethyltransferase oligomeric state THE FEBS JOURNAL 2015
Screening and in vitro testing of antifolate inhibitors of human cytosolic serine hydroxymethyltransferase CHEMMEDCHEM 2015
Molecular basis of E. coli l-threonine aldolase catalytic inactivation at low pH BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS 2015
On the mechanism of Escherichia coli pyridoxal kinase inhibition by pyridoxal and pyridoxal 5'-phosphate BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS 2015
The aspartate aminotransferase-like domain of Firmicutes mocr transcriptional regulators COMPUTATIONAL BIOLOGY AND CHEMISTRY 2015

ERC

  • LS1
  • LS1_2
  • LS1_4

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

My research activity has mainly concerned vitamin B6 metabolism, in humans and bacteria, and the mechanism, structure, regulation, metabolic role and inhibition of vitamin B6-dependent enzymes. At present, my interest is focused on the mechanisms of vitamin B6 homeostasis. On one side, I am investigating the transcriptional regulation of vitamin B6 biosynthesis and recycling pathways, focusing on bacterial organisms and the chimeric MocR proteins, which are PLP-binding transcriptional factors involved in the activation or repressor of vitamin B6 metabolism genes. On the other hand, I am studying the role of pyridoxal 5’-phosphate (PLP) carrier proteins, such as pyridoxine 5’-phosphate oxidase (PNPOx), pyridoxal kinase (PLK) and YggS, in controlling PLP homeostasis and delivery to apoenzymes in bacteria and humans. Besides, I am also committed to characterising the molecular basis of vitamin B6-dependend epilepsy, focusing my attention on missense mutations of human PNPOx. In this context, I am collaborating with clinicians to characterise novel mutations and correlate medical symptoms to the biochemical profile of patients. In recent years, I turned my attention to the role of serine hydroxymethyltransferase in the metabolic reprogramming of cancer cells, participating to two 3-year research programs funded by the Italian Association for Cancer Research (AIRC). My contribution to this field consisted in the study of the catalytic, structural and regulatory properties of both cytosolic and mitochondrial isoforms of the enzyme, the experimentation of novel inhibitors and the devise of in vivo activity assays. Lately, I have been involved in a project concerning the use of B6-enzymes as tools in the biosynthesis of unnatural amino acids and their intracellular incorporation in proteins and peptides.

Keywords

B vitamins
cell metabolism
enzyme
binding kinetics
Enzyme kinetics
homeostasis and regulation

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma